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Abstract 14 
Within host cells such as macrophages, Salmonella enterica translocates virulence 15 
(effector) proteins across its vacuolar membrane using the SPI-2 type III secretion 16 
system. Previously it has been shown that when expressed ectopically the effectors 17 
SseK1 and SseK3 inhibit TNFα-induced NF-κB activation. In this study we show that 18 
ectopically expressed SseK1, SseK2 and SseK3 suppressed TNFα-, but not TLR4-, 19 
or interleukin-induced NF-κB activation. Inhibition required a DXD motif, which in 20 
SseK1 and SseK3 is essential for protein Arginine-N-acetylglucosamine (GlcNAc)-21 
ylation. During macrophage infection, SseK1 and SseK3 inhibited NF-κB activity in 22 
an additive manner.  SseK3-mediated inhibition of NF-κB activation did not require 23 
the only known host-binding partner of this effector, the E3-ubiquitin ligase TRIM32. 24 
SseK proteins also inhibited TNFα-induced cell death during macrophage infection. 25 
Despite SseK1 and SseK3 inhibiting TNFα-induced apoptosis upon ectopic 26 
expression in HeLa cells, the percentage of infected macrophages undergoing 27 
apoptosis was SseK-independent. Instead, SseK proteins inhibited necroptotic cell 28 
death during macrophage infection. SseK1 and SseK3 caused GlcNAcylation of 29 
different proteins in infected macrophages suggesting that these effectors have 30 
distinct substrate specificities. Indeed, SseK1 caused the GlcNAcylation of the death 31 
domain containing proteins FADD and TRADD, whereas SseK3 expression resulted 32 
in weak GlcNAcylation of TRADD but not FADD. Additional, as yet unidentified 33 
substrates are likely to explain the additive phenotype of a Salmonella strain lacking 34 
both SseK1 and SseK3. 35 
 36 
 37 
 38 
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Introduction 39 
Salmonella enterica is a facultative intracellular pathogen whose serovars cause a 40 
range of diseases in mammals, associated with both localised and systemic 41 
infections. Numerous virulence proteins are important for the colonization and 42 
infection of its hosts (1). One important component of Salmonella virulence is the 43 
Salmonella pathogenicity island 2 (SPI-2)-encoded type III secretion system (T3SS) 44 
that enables the bacterium to translocate virulence (effector) proteins across the 45 
Salmonella-containing vacuole (SCV) into the host cell. To date approximately 30 46 
effectors have been identified that are translocated via this secretion apparatus (2). 47 
Several of these have been proposed or shown to interfere with the activity of key 48 
signalling pathways required for the induction of an innate immune response. These 49 
effectors include GogB (3), SspH1 (4), SpvC (5), SpvD (6) and GtgA (7). 50 
A major innate immune signalling pathway targeted by many bacterial pathogens 51 
(including Salmonella) is the Nuclear Factor-κB (NF-κB) pathway (8–12). This 52 
pathway is critical to drive the innate and adaptive immune responses including the 53 
induction of pro-inflammatory cytokines (13) and the control of cell survival (14). 54 
Various bacterial components and host cell cytokines such as tumour necrosis factor 55 
α (TNFα) activate this conserved signalling pathway of phosphorylation and 56 
ubiquitination events that culminates in the translocation of the NF-κB transcription 57 
factors into the host cell nucleus (15). TNFα binds to the TNF-receptor (TNFR1), 58 
which subsequently initiates the NF-κB pathway via death-domain containing 59 
proteins (16). In addition, engagement of TNFR1 by TNFα also initiates the formation 60 
of the death inducing signalling complex (DISC) consisting of FAS-associated death 61 
domain protein (FADD), TNFR1-associated death domain protein (TRADD) and pro-62 
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caspase-8, ultimately resulting in apoptotic cell death (17). Alternatively, if the levels 63 
of caspase-8 activity are low, then RIPK1 (rip interacting protein kinase 1) and 64 
RIPK3 associate, auto- and trans-phosphorylate each other and form a complex that 65 
phosphorylates MLKL (mixed lineage kinase domain-like), which is required for the 66 
induction of necroptosis (18–20).  67 
The enteropathogenic and enterohemorrhagic Escherichia coli T3SS effector NleB 68 
inhibits death domain-containing proteins, including FADD and TRADD, leading to 69 
reduced NF-κB pathway activation and impaired caspase-8-dependent host cell 70 
death during infection (21, 22). NleB is an N-acetylglucosamine (GlcNAc) transferase 71 
(21–23), that unlike host enzymes, catalyses a probably irreversible modification of 72 
arginine residue(s) within the death domains of target proteins (21). Salmonella 73 
enterica serovar Typhimurium (S. Typhimurium) encodes three SPI-2 T3SS effectors 74 
with sequence similarity to NleB (24): SseK1, SseK2 and SseK3. These effectors 75 
contain the essential divalent cation and/or sugar coordinating DXD motif that is 76 
required for enzymatic function of glycosyltransferases of the GT-A family (25).  77 
Despite their similarity to NleB, the SseK family remains poorly characterized. 78 
Following expression after transfection, SseK1 inhibits the NF-κB pathway, and like 79 
NleB, GlcNAcylates TRADD (21). Data by Yang et al, 2015 (26) suggested that 80 
SseK3 also inhibits the NF-κB pathway following transfection; however, direct 81 
evidence for SseK-mediated NF-κB inhibition during Salmonella infection is lacking.  82 
Here we report that both SseK1 and SseK3 inhibit Salmonella-induced NF-κB 83 
activation and necroptotic cell death during infection in macrophages. Transfection-84 
based experiments to delineate the selectivity of inhibition reveal specificity of all 85 
three SseK proteins towards TNFα-driven NF-κB activation, rather than inhibition of 86 
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signaling that is common to different stimuli. In addition, SseK proteins inhibited 87 
TNFα-induced cell death during macrophage infection. SseK3-mediated inhibition of 88 
NF-κB activation did not require the E3-ubiquitin ligase TRIM32, its only known 89 
binding partner (26). During infection of macrophages, expression of SseK1 and 90 
SseK3 led to clearly distinct profiles of Arginine-GlcNAcylated proteins. This, 91 
together with their differential ability to modify TRADD and FADD, reveal that the 92 
SseK effectors have distinct host cell targets during Salmonella infection. 93 
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Materials and Methods 94 
Bacterial strains and growth conditions 95 
The Salmonella Typhimurium strains (wild-type NCTC 12023 and its mutant 96 
derivatives) used in this study are listed in table S1. For flow cytometry, the indicated 97 
bacterial strains expressed GFP from pFPV25.1. Bacteria were grown in LB Broth at 98 
37°C in an orbital shaker. When appropriate, cultures were supplemented with 50 99 
µg/ml carbenicillin or 50 µg/ml kanamycin. 100 
 101 
Plasmid construction 102 
All plasmids and primers used in this study are detailed in tables S2 and S3. S. 103 
Typhimurium mutant strains were complemented with pWSK29 derivative plasmids 104 
(27). SseK1, SseK2 and SseK3 and their upstream promoter regions (200 bp, 200 105 
bp and 1000 bp respectively) were amplified from S. Typhimurium 12023 genomic 106 
DNA by PCR and ligated into pWSK29-2HA (28) using EcoRI and BamHI restriction 107 
sites. 108 
For effector expression in mammalian cells the open reading frames of SseK1, 109 
SseK2 and SseK3 were amplified from S. Typhimurium 12023 genomic DNA by 110 
PCR. Following sequence alignment with E. coli NleB, putative catalytic DAD motifs 111 
of the SseK proteins were identified. The SseKAAA were created by using overlap-112 
PCR with specific mutagenesis primers (29). NleB was amplified from genomic DNA 113 
of the E. coli O157:H7 Sakai strain (primers adapted from (22)). Full length FADD, 114 
TRADD and TRIM32 were amplified from murine cDNA. FADDR117A (primers from 115 
(22)) and TRADDR233A were created by overlap-PCR. Human DN IκBα (S32A/S36A) 116 
was described previously (30) (template gift F. Randow). The genes were cloned into 117 
the mammalian expression plasmids m4pGFP or m6pPAC-FLAG (both gifts from F. 118 
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Randow) resulting in proteins with an N-terminal GFP- or FLAG-tag, respectively. 119 
Renilla luciferase was amplified from pRLTK and ligated into m6pPAC without a tag.  120 
The ptCMV-GFP plasmid (this study) is a derivative from the pEGFP-N1 plasmid 121 
(Clonetech). All plasmids were checked by sequencing.  122 
 123 
Cell lines and culture 124 
RAW264.7 macrophages and HeLa cells used in this study were obtained from the 125 
European Collection of Animal and Cell Cultures (Salisbury, UK). 293ET cells were a 126 
gift from Felix Randow. Cells were cultured in Dulbecco’s modified Eagle’s medium 127 
(DMEM) (Sigma) supplemented with 10% foetal calf serum (FCS) (Sigma) at 37°C in 128 
5% CO2. Tlr4-/- immortalised BMDMs were created by infection of L929-differentiated 129 
bone marrow-derived macrophages (kind gift from Maria Belvisi and Dr Mark Birrell, 130 
Imperial College London) with the v-myc/v-raf expressing J2 retrovirus (31). Cells 131 
were then maintained in DMEM, 10% FCS, 20% L929-MCSF and 1 mM sodium 132 
pyruvate at 37°C, 5% CO2. NF-κB reporter macrophages were generated by 133 
retroviral transduction of RAW264.7 macrophages. Virus containing the 134 
m3psinrevκB-luc plasmid or the m6pPAC-RLuc plasmid was used for transduction 135 
as described previously (32).  Cells were simultaneously transduced with both 136 
viruses and subsequently selected with puromycin (1.5 µg/ml). 137 
 138 
Enbrel inhibition 139 
To inhibit TNFα stimulation of cells, RAW274.7 macrophages were pre-exposed to 140 
10 or 50 µg/ml Enbrel (Etanercept, Pfizer) for 30 min and subsequently infected with 141 
the indicated Salmonella strains. Exposure of cells to the drug was maintained 142 
throughout the full duration of the experiments.  143 
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 144 
Flow cytometry 145 
RAW264.7 macrophages were infected in 12-well plates with GFP-expressing 146 
Salmonella strains.  After 2 h, 16 h or 20 h of infection cells were washed with PBS 147 
and detached using Accutase (Sigma) for 15 min at room temperature. Cells were 148 
subsequently diluted in Opti-MEM (Invitrogen) and the GFP fluorescence intensity 149 
per cell analysed using a FACS Calibur flow cytometer (BD Biosciences).  Fold 150 
bacterial replication was calculated by comparing the GFP geometric means 151 
(Flowing Software, Version 2.5.1) of the 2 h and 16 h time points. To analyse 152 
caspase-3/-7 activity, RAW264.7 macrophages were infected for 20 h and caspase 153 
activity assayed using the SR-FLICA™ Caspase 3 & 7 Assay Kit (ImmunoChemistry 154 
Technologies) according to the manufacturer’s recommendation. Treatment of cells 155 
for 20 h with 50 µg/ml cycloheximide (Sigma) and 50 ng/ml TNFα (Sigma) was used 156 
as a positive control. Data were acquired using a Fortessa flow cytometer (BD 157 
Biosciences) and analysed with FlowJo (Version 8.8.6). Apoptotic RAW264.7 158 
macrophages were analysed at 20 h post-bacterial uptake using the Annexin-V 159 
Apoptosis Detection Kit APC (Ebioscience) according to the manufacturer’s 160 
recommendation. Staurosporine (Sigma) at 1 µM for 20 h was used as a positive 161 
control. Data were acquired on a FACS Calibur (BD Biosciences) and analysed with 162 
FlowJo software (Version 8.8.6). For all flow cytometry experiments data are the 163 
mean of three independent experiments with a minimum of 10,000 (infected) cells 164 
analysed in duplicate per sample.  165 
 166 
In vitro infection of cells 167 
9 
 
 
RAW264.7 macrophages were seeded at a density of 3 × 104 cells per well (96-well 168 
plate), 1 × 105 cells per well (24-well plate), 3 × 105 cells per well (12-well plate) or 6 169 
× 105 cells per well (6-well plate) 24 h prior to use. Stationary phase Salmonella 170 
cultures were opsonised in DMEM with 10% mouse serum for 20 min prior to 171 
macrophage infection (multiplicity of infection (MOI) of 10:1) by centrifugation for 5 172 
min at 110 × g and incubation for 25 min at 37°C. For SPI-1 mediated invasion of 173 
HeLa cells, stationary phase Salmonella strains were sub-cultured (1:33) for 3.5 h at 174 
37°C and HeLa cells (3 x105 cells/well, 6-well plate) were exposed to 25 µl of sub-175 
culture for 15 min. Cells were then washed in PBS and extracellular bacteria killed 176 
with medium containing 100 µg/ml gentamicin for 1 h. Subsequently the gentamicin 177 
concentration was reduced to 20 µg/ml for the remainder of the infection. To analyse 178 
Arginine-GlcNAcylated proteins and anti-HA immuno-precipitation experiments 1 × 179 
107 RAW264.7 macrophages were seeded in 15 cm Ø dishes 24 h before use. The 180 
macrophages were infected with stationary phase Salmonella at an approximate 181 
MOI of 30:1 for 30 min at 37°C. Subsequently the cells were washed and treated 182 
with gentamicin as described above. 183 
 184 
Immunofluorescence microscopy 185 
After 16 h of RAW264.7 macrophage infection, cells were fixed with 4% PFA for 20 186 
min at room temperature. Cells were subsequently washed with PBS and the PFA 187 
quenched with 100 mM Na4Cl for a minimum of 1 h at 4°C. Coverslips were labelled 188 
with the indicated primary antibodies for 2 h at room temperature, washed with PBS 189 
and incubated with the secondary antibodies and 4',6-diamidino-2-phenylindole 190 
(DAPI) for 1 h at room temperature. All antibodies were diluted in PBS, 0.1% (v/v) 191 
Triton X-100 (or saponin in Fig. 1A) and 10% horse serum. Goat anti-Salmonella 192 
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(CSA-1, Kirkegaard and Perry Laboratories), rat anti-HA (3F10, Roche), mouse anti-193 
GM130 (BD Biosciences), rabbit anti-Rab6 (C-19, Santa Cruz) and rabbit anti-194 
Arginine-GlcNAc (EPR18251, Abcam). The Alexa Fluor 488-, 555- and 633- 195 
conjugated donkey anti-goat, anti-rat, anti-mouse, and anti-rabbit secondary 196 
antibodies were purchased from Life Technologies, UK. Coverslips were mounted 197 
using Aqua-Poly/Mount (Polyscienes, Inc.) and imaged using a LSM 710 inverted 198 
confocal microscope (Zeiss GmbH). For quantitative analysis at least three 199 
independent experiments were performed in technical duplicates and a minimum of 200 
100 (infected) cells per coverslip were scored on an epifluorescence microscope 201 
(BX50, Olympus). 202 
 203 
NF-κB luciferase reporter assay 204 
NF-κB reporter macrophages were seeded in 24-well plates and infected as 205 
described above. After 16 h cells were lysed in 100 µl Passive Lysis Buffer 206 
(Promega). Alternatively, 5 × 104 293ET cells were seeded in 24-well plates 24 h 207 
prior to use. Transfection with Lipofectamine 2000 (Invitrogen) was performed 208 
according to the manufacturers recommendations with a mixture of 20 ng pRLTK, 50 209 
ng p4kB:Luc and 250 ng ptCMV-GFP-effector (or pEGFP-N1 control) plasmids. 24 h 210 
after transfection cells were stimulated overnight (approximately 17 h) with 50 ng/ml 211 
TNFα (Sigma), 10 ng/ml IL-1α (Sigma), 10 ng/ml IL-1β (Sigma) or 4 µg/ml high 212 
molecular weight (HMW) poly(I:C) (Invitrogen) and subsequently harvested in 100 µl 213 
Passive Lysis Buffer (Promega). To auto-activate the NF-κB pathway cells were 214 
transfected with 300 ng pEAKMMP-AU1-TLR4 (or m6pPAC-FLAG-GFP control) 215 
vector in addition to the plasmids described above for 24 h prior to harvesting cell 216 
lysates. Luciferase activity was measured using Dual Luciferase reporter assay 217 
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system (Promega) and a Tecan Infinite200 PRO plate reader. NF-κB regulated 218 
luciferase activity was normalised to Renilla luciferase intensity and is presented 219 
relative to either WT infected samples or unstimulated, GFP expressing control 220 
samples. In addition, fold changes between unstimulated and stimulated reporter 221 
activity per effector were calculated.  222 
 223 
Cell fractionation 224 
RAW264.7 macrophages were infected for 16 h, harvested and lysed for 30 min on 225 
ice in lysis buffer (150 mM NaCl, 0.3% (v/v) Triton X-100, 20 mM Tris-Cl (pH 7.4), 226 
5% glycerol, 5 mM EDTA, 1 mM PMSF, 1 mM Benzamide, 2 µg/ml Aprotinin, 5 µg/ml 227 
Leupeptin, 1 mM DTT). A fraction of the whole cell lysate was collected for analysis 228 
by SDS-PAGE and immuno-blotting. The remainder of the sample was centrifuged 229 
for 30 min at 16,000 × g at 4°C. The post-nuclear supernatant, containing 230 
cytoplasmic proteins, was separated from the pellet and analysed by SDS-PAGE 231 
and immuno-blotting.  232 
 233 
Immuno-precipitation experiments 234 
293ET cells were seeded in 6-well plates 24 h prior to use. 1 µg m6pPAC-FLAG-235 
FADD, m6pPAC-FLAG-TRADD or m6pPAC-FLAG-TRIM32 plasmid DNA together 236 
with 1 µg m6pPAC-FLAG-GFP, m4pGFP-SseK1, m4pGFP-SseK3, m4pGFP-NleB or 237 
200 ng ptCMV-GFP-SseK2 was transfected using Lipofectamine 2000 (Invitrogen) 238 
according to the manufactures instructions. 40 h later cells were harvested, lysed in 239 
lysis buffer and the post-nuclear supernatant isolated (see above). Proteins were 240 
immuno-precipitated using anti-FLAG M2 Affinity Gel (Sigma) for 2 h at 4°C. 241 
Samples were subsequently washed and analysed by SDS-PAGE and immuno-242 
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blotting. For infection anti-HA immuno-precipitation experiments RAW264.7 cells 243 
were seeded and infected for 16 h and proteins isolated as described above. Anti-HA 244 
Agarose (Pierce) was used to immuno-precipitate proteins, beads were 245 
subsequently washed and analysed by SDS-PAGE and immuno-blotting. For 246 
immuno-precipitations following transfection and infection, HeLa cells were 247 
transfected for 24 h with 1 µg of m6pPAC-FLAG-GFP, m4pGFP-FADD or m4pGFP-248 
TRADD plasmid using Lipofectamine 2000 (Invitrogen). Cells were then infected for 249 
16 h with the indicated Salmonella strains. Proteins were isolated as described 250 
above, immuno-precipitated using anti-GFP-Trap®_A beads (ChromoTek) and 251 
analysed by SDS-PAGE and immuno-blotting. 252 
 253 
LDH release assay 254 
RAW264.7 macrophages were infected in a 24-well plate as described above. After 255 
30 min of infection cells were then washed in PBS and extracellular bacteria killed in 256 
phenol red-free medium containing 100 µg/ml gentamicin for 1 h. The medium was 257 
diluted to a final concentration of 20 µg/ml gentamicin for the remainder of the 258 
infection (20 h). To analyse TNFα-induced cell death HeLa cells were transfected 259 
with 250 ng ptCMV-GFP-effector (or pEGFP-N1 control) plasmids for 24 h using 260 
Lipofectamine 2000 (Invitrogen). Cell death was subsequently stimulated with 10 261 
µg/ml cycloheximide (Sigma) and 50 ng/ml TNFα (Sigma) in phenol red-free 262 
medium. After 20 h of drug treatment or infection the supernatant was collected and 263 
extracellular lactate dehydrogenase levels measured with the CytoTox 96® Non-264 
Radioactive Cytotoxicity Assay kit (Promega) according to the manufacturer’s 265 
recommendation. Absorbance at 490 nm was measured on a Tecan Infinite200 PRO 266 
13 
 
 
plate reader. Salmonella induced cell death was calculated relative to a total cell 267 
death control (max). 268 
 269 
 270 
Quantitate reverse transcriptase (RT)-PCR 271 
Total RNA was isolated from 1 × 106 Tlr4-/- iBMDMs 16 h.p.u with the indicated 272 
bacterial strains (Qiagen RNAeasy Mini Kit). 400 ng total RNA was used to 273 
synthesise complementary DNA (cDNA) according to manufactures 274 
recommendations (QuantiTect RT Kit, Qiagen). Technical duplicate quantitative RT-275 
PCRs reactions (SybrGreen PCR master mix, Applied Biosystems) were prepared 276 
containing 0.2 µM gene-specific primers and 0.5 µl cDNA. Emission data and a 277 
significant cycle threshold (Ct) value from the Sybr Green reporter dye was acquired 278 
on a Rotor-Gene 3000 (Corbett Research). Relative mRNA was calculated from a 279 
titration curve of cDNA. Data represent the relative amounts of IL-6 mRNA, 280 
normalized to the Rps9 house keeping gene. The following primers were used: IL-6 281 
(For 5’- AGACAAAGCCAGAGTCCTTCAG-3’ and Rev 5’- 282 
GGTCTTGGTCCTTAGCCACTC-3’) Rps9 (For 5’- 283 
CTGGACGAGGGCAAGATGAAGC-3’ and Rev 5’- 284 
TGACGTTGGCGGATGAGCACA-3’). 285 
 286 
Propidium iodide uptake 287 
RAW264.7 macrophages were infected in a 96-well plate as described above. After 288 
30 min of infection cells were washed in PBS and incubated with medium (Opti-289 
MEM, 10% FCS) containing 30 µg/ml gentamicin. Propidium iodide (used at 1:1000, 290 
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Sigma) uptake was then measured on a Tecan Infinite200 PRO plate reader 291 
(excitation 530 nm, emission 617 nm) at 37°C in 5% CO2 for up to 20 h.p.u. PI 292 
uptake was calculated relative to a maximum control and normalised to 2 h.p.u. to 293 
account for experimental variation. Values shown are the mean of three independent 294 
experiments ±  s.e.m.  295 
 296 
SDS-PAGE and immuno-blotting 297 
Samples were separated on 10% SDS-PAGE gels and transferred onto PVDF 298 
Immobilon-P membranes (Millipore). Membranes were blocked and incubated with 299 
primary antibodies overnight at 4°C, washed and incubated for 2 h with HRP-coupled 300 
secondary antibodies at room temperature. All antibodies were diluted in 5% non-fat 301 
milk in TBST (100 mM Tris-Cl (pH 7.4), 150 mM NaCl, 0.1% (v/v) Tween-20). Mouse 302 
anti-DnaK (8E2/2, Enzo), mouse anti-HA.11 (16B12, Covanse), mouse anti-IκBα  303 
(L35A5, Cell Signaling), rabbit anti-IκBα phospho S32 (14D4, Cell Signaling), rabbit 304 
anti-FLAG (Sigma), rabbit anti-GFP (Invitogen), rabbit anti-Arginine-GlcNAc 305 
(EPR18251, Abcam), rabbit anti-MLKL (Sigma), rabbit anti-MLKL phospho S345 306 
(EPR9515(2), Abcam), rabbit anti-TRIM32 (Abcam), rabbit anti-tubulin (EPR16774, 307 
Abcam), rabbit anti-actin (Sigma). The HRP-conjugated goat, anti-mouse, and anti-308 
rabbit secondary antibodies were purchased from Dako. Immuno-blots shown are 309 
representative of three independent experiments.  310 
 311 
TRIM32 CRISPR-Cas9 312 
RAW264.7 macrophages were nucleofected (Lonza Kit V, as per the manufacturer’s 313 
recommendations) with 2 µg of plasmid pX330:T2A-GFP (Kind gift from F. Randow) 314 
carrying the guide RNA targeting Trim32 (GACATTCTAGCACTTCCCGGAGG). Two 315 
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days after transfection, cells were seeded in 96 well plates at a density of 0.3 cells / 316 
well.  Clonal populations were screened for expression of TRIM32 by Western blot 317 
analysis. Sanger sequencing confirmed genome editing of Trim32 in a clone lacking 318 
TRIM32 expression.   319 
 320 
Statistical analysis 321 
All presented values are expressed as mean ± standard error of the mean (s.e.m.) of 322 
at least three independent experiments. Statistical analysis was performed using 323 
Student’s t-test (two-tailed, unpaired) to compare two experimental groups. When 324 
comparing multiple groups statistical significances were calculated using one-way 325 
analysis of variance (ANOVA) and a post hoc Dunnett test. * P < 0.05; ** P < 0.01; 326 
*** P < 0.001. 327 
328 
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Results 329 
Translocation and intracellular localisation of SseK effectors in macrophages 330 
Translocation of SseK1, SseK2 and SseK3 into HeLa cells was shown previously 331 
(24, 33). To analyse the involvement of the Salmonella SseK effectors on NF-κB 332 
signalling and host cell death during infection of macrophages, plasmids were 333 
created that express HA-tagged SseK effectors under the control of their 334 
endogenous promoters. SPI-2 T3SS-dependent translocation of SseK1-HA, SseK2-335 
HA and SseK3-HA were detected in approximately 60% of infected RAW264.7 336 
macrophages at 16 hours post-uptake (h.p.u.) (Fig. 1A, 1B and S1). Translocated 337 
SseK1-HA was diffusely cytosolic with no specific subcellular localisation (Fig. 1A). 338 
In contrast, all cells positive for translocated SseK2-HA and SseK3-HA showed clear 339 
and well defined co-localisation of the effector with the host Golgi network (labelled 340 
with anti-Rab6 antibody) (Fig. 1A). This differential localisation of SseK1 and SseK3 341 
confirms previous studies using ectopically expressed effectors after transfection 342 
(26, 33).  343 
 344 
The E3-ubiquitin ligase Tripartite motif-containing protein 32 (TRIM32) is the only 345 
known host protein to interact with SseK3 (26). First, we tested if TRIM32 and the 346 
SseK effectors interact during infection. HA-tagged SseK3, but not SseK1-HA or 347 
SseK2-HA specifically bound endogenous TRIM32 in macrophage lysates prepared 348 
16 h post-uptake (Fig. 1C). TRIM32 localises to cytosolic peri-nuclear speckles (34, 349 
35) as well as to the Golgi network (26). To investigate if Golgi network localisation 350 
of SseK3-HA during infection depends on TRIM32, we generated TRIM32 null 351 
macrophages through the CRISPR-Cas9 method (36, 37) (Fig. 1D and S2A). 352 
Translocation of SseK3-HA in TRIM32 knockout macrophages was indistinguishable 353 
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from wild-type cells, occurring in approximately 70% of infected cells, with Golgi 354 
network localisation of SseK3-HA detected in 100% of cells containing the effector 355 
(Fig. 1E). Therefore, TRIM32 is not required for the translocation or localisation of 356 
SseK3.  357 
 358 
SseK1 and SseK3 inhibit the NF-κB pathway during Salmonella infection  359 
To investigate the effects of the SseK proteins on the NF-κB pathway during 360 
Salmonella infection we created a RAW264.7 macrophage reporter cell line that 361 
stably expresses a NF-κB-dependent Firefly luciferase gene and constitutively 362 
expresses Renilla luciferase as an internal control. These reporter cells were 363 
infected for 16 h with different Salmonella strains and luciferase levels were 364 
measured. First we confirmed that no replication defect of the mutant strains was 365 
apparent at this time point ((38), Fig. S3). Infection with wild-type Salmonella 366 
activated the reporter five-fold compared to uninfected control cells (Fig. 2A) showing 367 
NF-κB pathway responsiveness of the cell line to Salmonella infection. The SPI-2 368 
T3SS null mutant (ΔssaV), previously described to elicit an increased host cell 369 
immune response in Tlr4-/- macrophages (6), resulted in increased NF-κB reporter 370 
activity (Fig. 2A). To investigate if the loss of NF-κB pathway suppression by the 371 
ΔssaV mutant strain was due to the lack of SseK effector translocation we analysed 372 
single, double and triple SseK deletion mutant strains. There was significantly 373 
increased NF-κB pathway activity in cells infected with ΔsseK3, ΔsseK1/3 and 374 
ΔsseK1/2/3 compared to the wild-type strain (Fig. 2A). Notably, the double mutant 375 
strain ΔsseK1/3 had an additive effect compared to cells infected with either ΔsseK1 376 
(p value 0.0001) or ΔsseK3 strains (p value 0.0144). Decreased NF-κB suppression 377 
in macrophages infected with the ΔsseK1/3 strain was complemented by expression 378 
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of SseK1-HA or SseK3-HA from a low-copy number plasmid (Fig. 2B). Additional 379 
deletion of sseK2 (yielding the ΔsseK1/2/3 triple mutant) did not increase NF-κB 380 
pathway activity compared to the ΔsseK1/3 double mutant (Fig. 2A). Furthermore, in 381 
contrast to expression of SseK1-HA or SseK3-HA, expression of SseK2-HA from a 382 
low-copy number plasmid did not suppress the increase in NF-κB signalling of the 383 
ΔsseK1/2/3 triple mutant (Fig. 2C). Next we analysed activation of endogenous 384 
interleukin 6 (IL-6), a NF-κB regulated cytokine, during Salmonella infection. To 385 
reduce the potent effect of lipopolysaccharide (LPS) on pro-inflammatory cytokine 386 
expression which can mask the effect of SPI-2 T3SS-translocated proteins (6) we 387 
used Tlr4-/- iBMDMs (Toll like receptor 4 knockout immortalised bone marrow derived 388 
macrophages). Expression of SseK1-HA or SseK3-HA in the ΔsseK1/2/3 triple 389 
mutant resulted in significantly decreased IL-6 mRNA levels when compared to cells 390 
infected with the ΔsseK1/2/3pEmpty strain (Fig. 2D). Together, these results show 391 
that SseK1 and SseK3 function additively to inhibit the NF-κB signalling pathway 392 
during Salmonella infection.  393 
 394 
TRIM32 is not required for SseK3-mediated inhibition of NF-κB signalling 395 
Knockdown of TRIM32 decreases TNFα driven NF-κB signalling (26), suggesting 396 
that TRIM32 might function as an enhancer of NF-κB activation. To test directly if 397 
SseK3 interferes with NF-κB signalling in a TRIM32-dependent manner we 398 
introduced the NF-κB-dependent luciferase reporter and Renilla luciferase gene into 399 
macrophages lacking TRIM32.  Analysis of bacterial uptake (Fig. S2B) and 400 
replication by flow cytometry (Fig. S2C) or colony forming unit assay (Fig. S2D) did 401 
not reveal any significant differences between wild-type Salmonella and the 402 
ΔsseK1/2/3 triple mutant in RAW264.7 macrophages, a CRISPR control clone or the 403 
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TRIM32 knockout cells. As was observed for RAW264.7 macrophages, TRIM32 404 
knockout cells infected with ΔsseK1/2/3pEmpty displayed increased NF-κB-405 
dependent luciferase activity compared to cells infected with wild-type Salmonella or 406 
ΔsseK1/2/3 expressing SseK3 from a plasmid (Fig. 2E). Therefore, TRIM32 is not 407 
required for SseK3 to inhibit NF-κB signalling during infection of macrophages.  408 
 409 
Specific inhibition of TNFα-driven NF-κB signalling by SseK effectors 410 
It has been reported previously that SseK1 and SseK3 are sufficient to block TNFα-411 
driven NF-κB signalling when overexpressed in mammalian cells (21, 26). We 412 
confirmed these results: SseK1 and SseK3 inhibited the phosphorylation of IκBα 413 
after TNFα stimulation (Fig. S4A) and inhibited TNFα-induced NF-κB reporter 414 
activation (Fig. 3A). Mutation of the putative divalent cation and/or sugar coordinating 415 
DXD motif caused loss of pathway inhibition, despite equivalent levels of expression 416 
of wild-type and mutant proteins (Fig. 3A and 3B). Despite only weak inhibition in 417 
IκBα phosphorylation after SseK2 expression (Fig. S4A), SseK2 inhibited the NF-κB 418 
reporter after TNFα stimulation (Fig. 3A). Whether SseK2 is a bona fide inhibitor of 419 
NF-κB activation awaits additional work but it is noteworthy that in our infection 420 
experiments we were unable to identify a phenotype for SseK2 (Fig. 2).   421 
 422 
To better understand the specificity of NF-κB pathway inhibition, we measured 423 
reporter activation after effector plasmid transfection and pathway activation with a 424 
single stimulus. As a positive control, inhibition by dominant negative IκBα 425 
(S32A/S36A) was also analysed. Pro-inflammatory cytokines of the IL-1 family 426 
activate a distinct signalling pathway to TNFα that converges at the IκB kinase (IKK) 427 
complex upstream of NF-κB activation (15). As expected from previous work (39, 428 
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40), NleB was not an inhibitor of IL-1α or IL-1β-induced NF-κB activation (Fig. S4B 429 
and 3D). Also, whereas dominant negative IκBα inhibited NF-κB activity following 430 
stimulation with IL-1α (Fig. S4B) or IL-1β (Fig. 3D) none of the SseK proteins had a 431 
significant effect. A major activator of NF-κB during infection is bacterial LPS. To 432 
mimic LPS stimulation in 293ET cells the LPS receptor TLR4 was overexpressed to 433 
auto-activate the NF-κB signalling pathway. In contrast to TNFα stimulation, SseK1, 434 
SseK2 and SseK3 did not inhibit NF-κB activation downstream of TLR4 (Fig. 3E). 435 
Intracellular RIG-I like receptors (RLRs) activate NF-κB as well as the interferon 436 
regulated factor (IRF) family of transcription factors (41). As Salmonella RNA can 437 
enter the cytosol, thereby activating RIG-I-dependent signalling (42), we tested if 438 
SseK effectors inhibit RLR-induced NF-κB signalling after stimulation with 439 
polyinosinic:polycytidylic acid (poly(I:C)), a dsRNA mimic. As expected, dominant 440 
negative IκBα inhibited NF-κB activation but no inhibition occurred upon 441 
overexpression of GFP-tagged SseK1, SseK2 or SseK3 (Fig. 3F). Therefore the 442 
SseK effectors appear to have a TNFα-specific inhibitory effect on NF-κB signalling.   443 
 444 
Inhibition of the NF-κB pathway by NleB depends on its Arginine-GlcNAc transferase 445 
activity (21). We used SDS-PAGE and immuno-blotting with an Arginine-GlcNAc 446 
specific antibody (43) to visualise Arginine-GlcNAcylated proteins in cell lysates used 447 
for the reporter assay described above. Production of SseK1 and SseK3 as well as 448 
the positive control NleB resulted in a strong polydisperse smear of Arginine-449 
GlcNAcylated proteins (Fig. 3B). Loading less protein resolved individual bands 450 
representing Arginine-GlcNAcylated proteins induced by SseK1 and SseK3 (Fig. 451 
3C). Arginine-GlcNAcylation induced by SseK2 was only detected after normalisation 452 
of effector protein levels and very long exposure (Fig. S4C). Expression of the 453 
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putative catalytic mutants SseK1AAA and SseK3AAA, that did not inhibit NF-κB 454 
activation (Fig. 3A), failed to induce Arginine-GlcNAcylation (Fig. 3B). Therefore, 455 
SseK1- and SseK3-mediated inhibition of NF-κB activation is correlated with the 456 
Arginine-GlcNAcylation of cellular proteins. 457 
 458 
SseK1 and SseK3 expression leads to different Arginine-GlcNAcylation 459 
patterns 460 
Next we studied Arginine-GlcNAcylation induced by the SseK effectors under the 461 
more physiological conditions of infection. Salmonella-infected RAW264.7 462 
macrophages gave rise to an Arginine-GlcNAcylation signal in the cytosol and at the 463 
Golgi network that was detected in approximately 70% of the wild-type infected cells 464 
but completely absent in cells infected with the ΔsseK1/2/3 mutant (Fig. 4A and 4B). 465 
The ΔsseK1/2/3 mutant expressing SseK1 or SseK3 restored Arginine-466 
GlcNAcylation in the host cell cytoplasm (SseK1) or in both the cytoplasm and at the 467 
Golgi network (SseK3) (Fig. 4A and 4D). No Arginine-GlcNAcylated proteins were 468 
detected in the ΔsseK1/2/3pSseK2 strain, despite clear translocation of the HA-469 
tagged effector (Fig. 4A and 4C).  470 
 471 
The differential subcellular localisation of Arginine-GlcNAcylated proteins upon 472 
expression of SseK1 or SseK3 suggested that these enzymes might target different 473 
substrates during infection. To test this directly RAW264.7 macrophages were 474 
infected for 16 h with different Salmonella strains and proteins were analysed by 475 
SDS-PAGE and immuno-blotting. Several Arginine-GlcNAcylated proteins were 476 
detected after infection with wild-type Salmonella (Fig. 5A and 5B). Deletion of sseK2 477 
produced no detectable effect on the Arginine-GlcNAcylation pattern when compared 478 
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to wild-type infected cells (Fig. 5A). In agreement with this, no Arginine-GlcNAcylated 479 
proteins were detected after infection with the ΔsseK1/3 mutant strain (Fig. 5A). 480 
Furthermore, and in line with the fluorescence microscopy (Fig. 4A), expression of 481 
SseK2 in the ΔsseK1/2/3 mutant strain did not result in detectable Arginine-482 
GlcNAcylated proteins (Fig. 5B). In contrast, single deletion of sseK1 or sseK3 led to 483 
the loss of individual GlcNAcylated proteins on the immuno-blot suggesting effector-484 
specific target proteins (Fig. 5A). Notably, a strong band corresponding to a protein 485 
of approximately 30 kDa (indicated by *) and a second protein of approximately 40 486 
kDa (indicated by ‡) were absent in macrophages infected with the ΔsseK1 but not 487 
ΔsseK2 or ΔsseK3 strains (Fig. 5A). Overexpression of translocated SseK1 from a 488 
low-copy plasmid restored two bands with the same approximate molecular mass of 489 
the bands absent after infection with the ΔsseK1 strain (* and ‡ respectively), 490 
indicating that they are physiological targets of SseK1 (Fig. 5A and 5B). Additional 491 
prominent bands at approximately 65 and 95 kDa (bands a and b respectively) 492 
became apparent specifically when SseK1 was overexpressed from bacteria (Fig. 493 
5B).  494 
 495 
Following infection with the ΔsseK3 strain, at least 6 discernable GlcNAcylated 496 
proteins from 55-100 kDa were absent (indicated by #) when compared to 497 
macrophages infected with wild-type Salmonella (Fig. 5A). GlcNAcylated proteins of 498 
corresponding molecular masses were restored when macrophages infected with 499 
ΔsseK1/2/3pSseK3 were analysed (Fig. 5B). In addition, 3 strong bands were 500 
detected of approximately 32, 35 and 43 kDa (bands c, d and e). It is noteworthy that 501 
the 9 strong bands detected upon plasmid-based expression of SseK3 are all of 502 
23 
 
 
different molecular masses to those detected after infection with ΔsseK1/2/3pSseK1 503 
(Fig. 5B), strongly suggesting differential substrate specificity of these effectors.  504 
 505 
Analysis of potential targets  506 
Yang et al., (2015) showed that despite stable binding of SseK3 to TRIM32, no 507 
GlcNAc modification of TRIM32 was detected when using an antibody against O-508 
GlcNAc post translational modifications. Similarly, despite binding of GFP-SseK3 to 509 
FLAG-TRIM32 we detected no Arginine-GlcNAcylation of TRIM32 (Fig. 6A). Based 510 
on the high level of amino acid identity between NleB and the SseK effectors (24) we 511 
hypothesised that the SseK proteins might also Arginine-GlcNAcylate death-domain 512 
containing proteins (21, 22). To test this, FLAG-tagged FADD or TRADD, two known 513 
NleB targets, were expressed together with SseK1, SseK2 or SseK3 in 293ET cells 514 
and enriched by anti-FLAG immuno-precipitation. As expected, NleB bound FADD 515 
stably and caused its Arginine-GlcNAcylation (Fig. 6B). Even though stable binding 516 
between SseK1 and FADD was not detected, overexpression of the SseK1 resulted 517 
in Arginine-GlcNAcylation of FADD (Fig. 6B). Modification of FADD was not detected 518 
when expressed in the presence of SseK2 or SseK3 (Fig. 6B). Similar to FADD, no 519 
stable effector binding to TRADD was detected but the protein was GlcNAcylated 520 
when co-expressed with SseK1 or NleB in line with previously reported findings (21). 521 
Very minor modification of TRADD was observed when SseK3 was co-expressed 522 
(Fig. 6C). These data demonstrate target specificity between SseK1 and SseK3, in 523 
line with our observation that different proteins are Arginine-GlcNAcylated by these 524 
effectors during infection. 525 
 526 
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Next we used arginine mutants of FADD and TRADD to test whether SseK1 and 527 
NleB induce GlcNAcylation of the same amino acid residue in these proteins. 528 
FADDR117A was not GlcNAcylated upon expression of SseK1 or NleB, indicating that 529 
both effectors target the same residue in the death domain of FADD (Fig. 6D). In 530 
contrast, TRADDR233A was still modified when co-expressed with SseK1 but not 531 
NleB, suggesting that SseK1-mediated GlcNAcylation of TRADD occurs on either a 532 
different amino acid or on multiple arginine residues (Fig. 6E).  533 
 534 
Finally, we tested if FADD and TRADD were modified after bacterial-mediated 535 
delivery of SseK proteins. Transiently expressed GFP-tagged FADD or TRADD, or 536 
GFP alone (as a control), were immuno-precipitated from non-infected HeLa cells or 537 
cells infected with WTpEmpty, ΔsseK1/2/3pEmpty or ΔsseK1/2/3 strains expressing 538 
SseK1, SseK2 or SseK3 (Fig. 7). Infection-induced Arginine-GlcNAcylation of FADD 539 
and TRADD (but not the GFP control) was dependent on the SseK proteins: SseK1 540 
modified FADD (Fig. 7, middle panel) while both SseK1 and SseK3 induced 541 
modification of TRADD (Fig. 7, right hand panel). Therefore, FADD and TRADD are 542 
likely to represent genuine targets of SseK proteins during host cell infection.   543 
 544 
SseK1 and SseK3 inhibit cell death during Salmonella infection  545 
GlcNAcylation of FADD and TRADD by NleB results in inhibition of cell death as well 546 
as inhibition of NF-κB signalling (21, 22), we therefore tested if SseK proteins also 547 
inhibit cell death. First we analysed the uptake of propidium iodide (PI), a membrane 548 
impermeable dye, by infected macrophages over time. Macrophages infected with 549 
wild-type Salmonella showed increased levels of PI uptake compared to uninfected 550 
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cells and this was further increased when cells were infected with the ΔsseK1/2/3 551 
mutant strain (Fig. 8A and S5A). Next we analysed cell death by release of lactate 552 
dehydrogenase (LDH) at 20 h.p.u, when significant differences were observed in PI-553 
uptake between the ΔsseK1/2/3 mutant and wild-type Salmonella. LDH release was 554 
significantly increased in macrophages infected with the ΔsseK1/2/3 mutant when 555 
compared to wild-type infected cells. Expression of SseK1 or SseK3 (but not SseK2) 556 
in the ΔsseK1/2/3 mutant was sufficient to reduce LDH release (Fig. 8B and S5B) 557 
revealing that during infection, both SseK1 and SseK3 inhibit Salmonella-induced 558 
cell death. 559 
 560 
Similar to NleB (21, 22), SseK1 and SseK3 inhibited TNFα plus cycloheximide-561 
induced apoptosis in HeLa cells (Fig. 8C and S5C). Therefore we tested if SseK 562 
effectors inhibit TNFα-induced cell death during infection of macrophages. First we 563 
confirmed that pharmacological inhibition of extracellular TNFα (using Enbrel, which 564 
binds to TNFα (44–46)) reduced TNFα-mediated activation of the NF-κB reporter in a 565 
dose dependent manner (Fig. S5D). The addition of Enbrel, which did not affect the 566 
uptake (Fig. S5E) or replication (Fig. S5F) of Salmonella, abrogated the increased 567 
LDH release normally detected in macrophages infected with ΔsseK1/2/3 mutant 568 
bacteria (Fig. 8D). Therefore, during infection, exogenous TNFα induces cell death in 569 
the absence of SseK-mediated inhibition.  570 
 571 
Activation of the TNFR can induce apoptosis or necroptosis, depending on the 572 
amount of caspase activity (47, 48). To test if macrophages infected with ΔsseK1/2/3 573 
mutant Salmonella undergo enhanced apoptosis we determined the proportion of 574 
Annexin-V (which binds phosphatidylserine on the extracellular surface of apoptotic 575 
26 
 
 
cells) -positive cells by flow cytometry. Approximately 15% of infected cells were 576 
Annexin-V positive, whether the bacteria expressed SseK proteins or not (Fig. 8E). 577 
Death-receptor signalling activates caspase-8, which cleaves and activates caspase-578 
3 during apoptosis. Therefore, as an alternative readout for the induction of 579 
apoptosis we measured the amount of caspase-3/-7 activity in infected 580 
macrophages. No differences in caspase-3/-7 activity were detected after 20 hours 581 
of infection with either wild-type or ΔsseK1/2/3 mutant Salmonella (Fig. 8F and S5G). 582 
In contrast to apoptosis, necroptotic cell death depends on the phosphorylation and 583 
activation of MLKL (18–20). In comparison to wild-type Salmonella-infected 584 
macrophages, those infected with the ΔsseK1/2/3 mutant exhibited strikingly 585 
enhanced levels of phospho-MLKL (Fig. 8G). The enhanced levels of phospho-MLKL 586 
were reduced in ΔsseK1/2/3 strains expressing SseK1 or SseK3, but not SseK2. 587 
Together, our data indicate that during macrophage infection SseK1 and SseK3 588 
function to inhibit TNFα-induced necroptotic cell death.   589 
  590 
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Discussion 591 
Two comprehensive studies showed that the Arginine-GlcNAcylation of death 592 
domain proteins including TRADD and FADD by the E. coli effector protein NleB 593 
results in inhibition of NF-κB signalling and cell death (21, 22). The Salmonella 594 
genome encodes three proteins with high amino acid identity to NleB (24). By using 595 
mutant strains and transient transfection to analyse the function of SseK proteins we 596 
investigated their relative contributions to immune regulation. We found that during 597 
macrophage infection SseK1 and SseK3 inhibited NF-κB signalling in an additive 598 
manner and also suppressed host cell death. Ectopic overexpression of SseK2 599 
resulted in inhibition of TNFα-induced NF-κB reporter activation, which was 600 
dependent on its DXD motif, indicating that it mediates this effect enzymatically. 601 
However, whether this activity is non-specific or of physiological relevance is unclear 602 
as we were unable to detect altered NF-κB induction or Arginine-GlcNAcylation by 603 
SseK2 during infection of macrophages with Salmonella, despite clear evidence of 604 
effector translocation. Therefore, while it remains conceivable that GlcNAcylated 605 
proteins induced by SseK2 during infection are below the level of detection, it is also 606 
possible that this effector does not act as an Arginine-GlcNAc transferase within 607 
macrophages. SseK2 might have evolved to preferentially catalyse the 608 
GlcNAcylation of different amino acid residue(s) or to transfer a different saccharide 609 
moiety that is not detected by the antibody used here. Whatever its biochemical 610 
activity, inhibition of NF-κB activation during mouse macrophage infection seems 611 
unlikely to be the primary function of SseK2.  612 
 613 
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In contrast to SseK2, both SseK1 and SseK3 induced specific and distinct Arginine-614 
GlcNAcylation of several proteins during infection of macrophages. Given the high 615 
degree of similarity between SseK proteins and NleB (in terms of amino acid 616 
sequence, conservation of the essential DXD motif and functional inhibition of TNFα-617 
induced NF-κB signalling), we tested if SseK effectors also induce the Arginine-618 
GlcNAcylation of TRADD and FADD. We confirmed a previous finding that SseK1 619 
induces GlcNAcylation of overexpressed TRADD (21) and also detected SseK1-620 
dependent Arginine-GlcNAcylation of FADD, despite the lack of stable binding 621 
between SseK1 and these host proteins. Like NleB, SseK1 induced GlcNAcylation of 622 
R117 on FADD, indicating that it has the same activity. In contrast to NleB, SseK1 623 
still promoted Arginine-GlcNAcylation of a TRADD variant in which the arginine 624 
residue modified by NleB (R233) was mutated. Evidently, SseK1 modifies either 625 
different or multiple arginine residue(s) in TRADD. SseK1-mediated modification of 626 
overexpressed TRADD and FADD was detected in HeLa cells after translocation of 627 
the effector from bacteria. After macrophage infection, several proteins of a similar 628 
molecular weight to TRADD were GlcNAcylated in an SseK1-dependent manner 629 
(Fig. 5A), but which (if any) of these represent TRADD remains to be established. 630 
 631 
In contrast to SseK1 and NleB, ectopic expression of SseK3 did not induce 632 
detectable Arginine-GlcNAcylation of FADD and caused much weaker TRADD 633 
modification than either SseK1 or NleB. In support of SseK3-mediated modification 634 
of TRADD, bacterially delivered SseK3 modified overexpressed TRADD in HeLa 635 
cells. The only known host protein that binds to SseK3 (upon ectopic expression) is 636 
the E3-Ubiquitin ligase TRIM32 (26), and we established that this interaction also 637 
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occurs in infected macrophages. Nearly half of all TRIM proteins are innate immune 638 
enhancers and TRIM32 can bind/modify several proteins involved in NF-κB 639 
signalling including IRAK1, PIASy and STING (49–51), making TRIM32 a plausible 640 
candidate for SseK3-mediated GlcNAcylation. However, no modification of TRIM32 641 
by SseK3 was detected by Yang et al (2015) using an anti-O-GlcNAc antibody, or 642 
using the anti-Arginine-GlcNAc specific antibody (this study). As TRIM32 can self-643 
associate into tetramers (52) a second hypothesis was that it might function as a 644 
structural scaffold for SseK3 function rather than being a direct effector target. 645 
However, SseK3 still inhibited NF-κB activation during infection of macrophages 646 
lacking TRIM32. Therefore, the physiological significance of the SseK3-TRIM32 647 
interaction remains enigmatic.  648 
 649 
A double mutant strain lacking SseK1 and SseK3 produced significantly more NF-κB 650 
reporter activation than either single mutant, suggesting that these effectors are not 651 
functionally redundant. Furthermore, the bacterial mutants and complemented 652 
strains produced patterns of GlcNAcylation on western blots that enabled at least 653 
two proteins (approximately 30 and 40 kDa) to be assigned to SseK1 and at least six 654 
proteins (of 55 – 100 kDa) to be assigned to SseK3. The identities of these proteins 655 
are currently unknown but they clearly indicate distinct targets for SseK1 and SseK3. 656 
Since the effectors did not inhibit TLR4, IL-1α/β or poly(I:C)-induced NF-κB 657 
signalling, we conclude that at least some of the putative targets are likely to be 658 
components of the TNFα-specific arm of this pathway.  659 
 660 
During infection, rapid NF-κB activation occurs upon recognition of LPS by TLR4 661 
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(53). In the mouse model of infection, the influence of TNFα in controlling bacterial 662 
growth only becomes apparent several days after inoculation (54). Since SPI-2 T3SS 663 
effectors are expressed and translocated by intracellular bacteria, following vacuole 664 
acidification and assembly of the secretion apparatus (55–57) it is not surprising that 665 
the SseK family has evolved to inhibit TNFα- but not TLR4-induced signalling. This 666 
agonist-specific inhibition appears to distinguish SseK1 and SseK3 from other NF-667 
κB-inhibiting effectors of Salmonella. These include GtgA, GogB and SpvD, which 668 
target proteins common to numerous agonists (3, 6, 7).  669 
 670 
Finally, we have shown that SseK1 and SseK3 inhibit necroptotic cell death during 671 
macrophage infection. Whether they inhibit apoptotic cell death during infection in 672 
cells that undergo higher levels of apoptosis awaits further investigation. The 673 
inhibition of death-domain proteins such as FADD and TRADD provides an 674 
explanation for how SseK1 and possibly SseK3 inhibit TNFα-induced cell death in 675 
addition to NF-κB activation.  Inhibition of both pro-inflammatory signalling and host 676 
cell death by SseK1 and SseK3 could provide Salmonella with robustness and 677 
flexibility in counteracting host immune responses.  678 
  679 
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Figure legends 866 
Fig 1. SseK effector translocation and localisation into macrophages  867 
(A) Representative images by confocal immunofluorescence microscopy of 868 
RAW264.7 macrophages infected with wild-type or indicated mutant Salmonella 869 
strains expressing HA-tagged SseK effectors at 16 h.p.u. Salmonella (α-CSA-1, 870 
grey); effectors (α-HA, red); Golgi (α-Rab6, green); DNA (DAPI, blue). Scale bar 5 871 
µm. Effector co-localisation with the Golgi network is highlighted with arrows. (B) 872 
Percentage of infected cells with translocated HA-tagged SseK effectors quantified 873 
by immunofluorescence microscopy at 16 h.p.u. A total of at least 600 infected cells 874 
were counted in three independent experiments. Values shown as mean ± s.e.m. (C) 875 
RAW264.7 macrophages were infected for 16 h with the indicated Salmonella 876 
strains, lysed and proteins immuno-precipitated with α-HA agarose. Samples were 877 
analysed by SDS-PAGE and immuno-blotted for effectors (α-HA) and TRIM32 (α-878 
TRIM32). Data representative of three independent experiments. (D) Representative 879 
immuno-blot of RAW264.7 TRIM32 knockout cell post-nuclear cytosolic extracts. A 880 
clonal population of cells that went through the CRISPR knockout procedure 881 
unsuccessfully serve as a negative control. TRIM32 (α-TRIM32), loading control (α-882 
actin). Data representative of three independent experiments. (E) Representative 883 
images by confocal immunofluorescence microscopy of WT or TRIM32 knockout 884 
RAW264.7 macrophages infected with Salmonella strain ΔsseK3pSseK3-HA at 16 885 
h.p.u. Salmonella (α-CSA-1, grey); effectors (α-HA, red); Golgi (α-Rab6, green); DNA 886 
(DAPI, blue). Scale bar 5 µm. 887 
 888 
 889 
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Fig 2. SseK1 and SseK3 inhibit the NF-κB pathway in an additive manner 890 
during macrophage infection 891 
(A-C) RAW264.7 macrophages stably transduced with a NF-κB-dependent luciferase 892 
gene and constitutively expressing Renilla luciferase as an internal control were 893 
infected for 16 h with the indicated Salmonella strains. Results are represented as 894 
mean fold activation relative to wild-type infection from five independent experiments 895 
± s.e.m. * P < 0.05; ** P < 0.01, *** P < 0.001. All data were acquired at the same 896 
time. The UI, WTpE, ΔsseK1/3pE or ΔsseK1/2/3pE data are reproduced in each 897 
subfigure for ease of interpretation. UI; uninfected. pE; empty control vector. (D) 898 
Quantitative RT-PCR analysis of IL-6 mRNA levels in infected Tlr4-/- iBMDM 16 899 
h.p.u. IL-6 mRNA expression was normalised to Rps9 mRNA and is presented as 900 
fold to WT infected cells. Results are represented as mean from six independent 901 
experiments ± s.e.m. * P < 0.05; ** P < 0.01. (E) WT or TRIM32 knockout RAW264.7 902 
NF-κB reporter macrophages were infected for 16 h with the indicated Salmonella 903 
strains. Results are represented as mean fold activation relative to wild-type infection 904 
from three independent experiments ± s.e.m. * P < 0.05; *** P < 0.001. UI; 905 
uninfected. pE; empty control vector. 906 
 907 
Fig 3. Salmonella SseK effectors selectively inhibit TNFα mediated NF-κB 908 
signalling 909 
 (A, D-F) 293ET cells were co-transfected with an NF-κB -dependent luciferase 910 
reporter plasmid, pTK-Renilla luciferase plasmid and indicated ptCMV-GFP-effector 911 
plasmids. Alternatively, dominant negative IκBα was used as a control. The NF-κB 912 
pathway was activated overnight with 50 ng/ml TNFα (A), 10 ng/ml IL-1β (D), 4 µg/ml 913 
HMW poly(I:C) (F) or overexpression of TLR4 for 24 h (E) prior to cell lysis and 914 
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analysis of luciferase activity. Results from (D) and (F) were acquired at the same 915 
time and contain the same unstimulated control data. Results are presented as fold 916 
activation relative to unstimulated, GFP expressing control cells. Data shown are 917 
mean of 4-7 independent experiments ± s.e.m. * P < 0.05; *** P < 0.001. (B) Cell 918 
lysates from (A) were analysed by SDS-PAGE and immuno-blotting to determine 919 
effector protein expression levels during NF-κB transfection reporter experiments. 920 
Effectors (α-GFP), Arginine-GlcNAc (α-Arg-GlcNAc), loading control (α-actin, α-921 
tubulin). (C) Amount of cell lysate was adjusted to normalise GFP-effector levels and 922 
samples analysed as described for (B).  923 
 924 
Fig 4. SseK-dependent differential localisation of Arg-GlcNAcylated proteins in 925 
infected macrophages  926 
(A) Representative confocal immunofluorescence microscopy images of Arg-GlcNAc 927 
patterns in RAW264.7 macrophages infected with wild-type or indicated mutant 928 
Salmonella strains expressing HA-tagged SseK effectors at 16 h.p.u. Salmonella (α-929 
CSA-1, grey); effectors (α-HA, red); Arginine-GlcNAc (α-Arg-GlcNAc, green); DNA 930 
(DAPI, blue). Scale bar 5 µm. (B) Percentage of infected cells with Arg-GlcNAcylated 931 
proteins quantified from (A). (C) Percentage of infected cells with translocated 932 
effector that show a positive Arg-GlcNAc signal quantified from (A). Data are mean ± 933 
s.e.m. of three independent experiments where at least 600 infected cells were 934 
counted in total. *** P < 0.001. (D) Representative images of Arg-GlcNAcylation and 935 
Golgi (α-GM130, grey) co-localisation in RAW264.7 macrophages.  Scale bar 5 µm. 936 
UI; uninfected. pE; empty vector control.  937 
 938 
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Fig 5. Expression of SseK1 and SseK3 results in different patterns of Arg-939 
GlcNAcylated proteins during infection of macrophages 940 
(A-B) RAW264.7 macrophages were infected with indicated Salmonella strains for 941 
16 h. Post nuclear extracts were isolated and Arginine-GlcNAcylated proteins 942 
analysed by SDS-PAGE and immuno-blotting. Where indicated, translocated HA-943 
tagged effectors were also probed. Whole cell lysates were analysed to control for 944 
bacterial loads.  Arginine-GlcNAc (α-Arg-GlcNAc), Salmonella (α-DnaK), effectors (α-945 
HA), loading control (α-tubulin). Data representative of three independent 946 
experiments. UI; uninfected. pE; empty vector control. The symbols * and ‡ highlight 947 
SseK1 specific Arginine-GlcNAcylated proteins. The # and bracket highlight a range 948 
of SseK3 specific Arginine-GlcNAcylated proteins. 949 
 950 
Fig 6. Arg-GlcNAcylation profile of FADD and TRADD upon SseK expression 951 
(A-E) Plasmids encoding GFP-tagged effectors and FLAG-tagged putative target 952 
proteins were co-transfected into 293ET cells. 40 h after transfection cells were lysed 953 
and proteins immuno-precipitated with α-FLAG conjugated beads. Samples were 954 
analysed by SDS-PAGE and immuno-blotting for effectors (α-GFP), 955 
TRIM32/FADD/TRADD (α-FLAG), Arginine-GlcNAc (α-ArgGlcNAc), loading control 956 
(α-tubulin or α-actin). Data representative of three independent experiments. 957 
 958 
Fig 7. Arg-GlcNAcylation profile of FADD and TRADD during Salmonella 959 
infection 960 
Plasmids encoding GFP (left hand panel), GFP-FADD (middle panel) and GFP-961 
TRADD (right hand panel) were transfected into HeLa cells. 24 h after transfection 962 
cells were infected with the indicated Salmonella strains.  After 16 h of infection, cells 963 
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were lysed and proteins immuno-precipitated with α-GFP conjugated beads. 964 
Samples were analysed by SDS-PAGE and immuno-blotting for effectors (α-HA), 965 
FADD/TRADD (α-GFP), Arginine-GlcNAc (α-ArgGlcNAc), Salmonella (α-DnaK) and 966 
loading control (α-tubulin). The positive control in the left panel is GFP-TRADD 967 
transfected cells infected with WTpE Salmonella as in the right hand panel. Data 968 
representative of three independent experiments. UI; uninfected. pE; empty vector 969 
control.   970 
 971 
Fig 8. SseK1 and SseK3 inhibit TNFα induced cell death in macrophages 972 
(A) RAW264.7 macrophages were infected with wild-type or mutant Salmonella 973 
strains and cell death assayed by propidium iodide (PI) uptake over time. Results 974 
from three independent experiments were calculated relative to maximum PI uptake 975 
and are presented as a mean fold increase relative to 2 h.p.u. ± s.e.m. * P < 0.05.  976 
(B) Lactate dehydrogenase release from RAW264.7 macrophages infected for 20 h 977 
with the indicated Salmonella strains. Salmonella induced cell death was calculated 978 
and normalised to WT infected cells. Data presented are the mean of eight 979 
independent experiments ± s.e.m. * P < 0.05; ** P < 0.01. (C) LDH release from 980 
transfected HeLa cells expressing GFP-tagged SseK effectors. Cell death was 981 
stimulated with 10 μg/ml cyclohexamide (CHX) and 50 ng/ml TNFα for 20 h. Data 982 
presented are the mean of nine independent experiments ± s.e.m. * P < 0.05; *** P < 983 
0.001. (D) LDH release from RAW264.7 macrophages infected for 20 h with the 984 
indicated strains and treated with water, the TNFα inhibitor Enbrel (Etanercept) or an 985 
antibody (Ab) control used at 50 µg/ml. Data are normalised to uninfected, water 986 
treated control cells and represent the mean of six independent experiments  ± 987 
s.e.m. * P < 0.05. (E) RAW264.7 macrophages were infected for 20 h with the 988 
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indicated GFP-expressing strains and Annexin-V labelling of infected cells was 989 
analysed by flow cytometry. Staurosporine (1 μM) was used as a positive control to 990 
induce apoptosis. Data are the mean of three independent experiments ± s.e.m. (F) 991 
Caspase-3/7 activity was assayed using an SR-DEVD-FMK FLICA probe at 20 h.p.u. 992 
in macrophages infected with the indicated GFP-expressing strains. The data, which 993 
represent the mean and s.e.m. of three independent experiments, was analysed by 994 
flow cytometry and is represented as the fold activity of infected / uninfected cells 995 
from the same sample. (G) RAW264.7 macrophages were infected with the indicated 996 
Salmonella strains for 20 h. MLKL phosphorylation and effector translocation was 997 
analysed in whole cell lysates and post-nuclear supernatants by SDS-PAGE and 998 
immuno-blotting. Phospho-MLKL (α-ph-MLKL), MLKL (α-MLKL), effectors (α-HA), 999 
Salmonella (α-DnaK), loading control (α-tubulin). Data representative of three 1000 
independent experiments. UI; uninfected. 1001 
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